FindTrial
Sign In

Affect of cancer in mouth and throat and its treatment on mouth opening

Assessment of prevalence and factors affecting trismus in cases of oral and oropharyngeal malignancies after complete treatment

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/10/028771
Enrollment
50
Registered
2020-10-29
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: C01- Malignant neoplasm of base of tongue Health Condition 2: C10- Malignant neoplasm of oropharynx

Interventions

None listed

Sponsors

Kasturba Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Newly diagnosed cases of oral and oropharyngeal malignancies who are seeking treatment in the Dept of ENT or Dept of Surgical oncology

Exclusion criteria

Exclusion criteria: Patients with prior history of malignancy in upper aerodigestive tract, edentulos patients, those lost to follow up or not completing treatment

Design outcomes

Primary

MeasureTime frame
The degree of trismus is assessed in each patient and factoras resonsible are determinedTimepoint: Before treatment, 1 month and 6 months after treatment—

Secondary

MeasureTime frame
Correlation of trismus with clinico-pathological factors and to determine prevalence of trismusTimepoint: Evaluated aat 1 month and 6 months duration—

Countries

India

Contacts

Public ContactDr Shama Shetty

Kasturba Medical College, Manipal

shama.shetty@manipal.edu7760557950

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026